Reiner Leidl

Personal Details

First Name:	Reiner
Middle Name:	Martin
Last Name:	Leidl
Suffix:
RePEc Short-ID:	ple1128
	[This author has chosen not to make the email address public]

Affiliation

(50%) Fakultät für Betriebswirtschaft
Ludwig-Maximilians-Universität München

München, Germany
http://www.bwl.uni-muenchen.de/
RePEc:edi:fbmunde (more details at EDIRC)

(50%) Institute für Gesundheitsökonomie und Management im Gesundheitswesen (IGM)
Helmholtz Zentrum für Gesundheit und Umwelt

München, Germany
http://www.helmholtz-muenchen.de/igm/
RePEc:edi:igmhzde (more details at EDIRC)

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:

1. Kristina Burström & Fitsum Sebsibe Teni & Ulf-G. Gerdtham & Reiner Leidl & Gert Helgesson & Ola Rolfson & Martin Henriksson, 2020. "Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States," PharmacoEconomics, Springer, vol. 38(8), pages 839-856, August.

   Mentioned in:

   1. Chris Sampson’s journal round-up for 3rd August 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-08-03 11:00:00

Working papers

1. Lutter, Johanna I. & Szentes, Boglarka & Wacker, Margarethe E. & Winter, Joachim & Wichert, Sebastian & Peters, Annette & Holle, Rolf & Leidl, Reiner, 2019. "Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study," Munich Reprints in Economics 78227, University of Munich, Department of Economics.
   • Johanna I. Lutter & Boglárka Szentes & Margarethe E. Wacker & Joachim Winter & Sebastian Wichert & Annette Peters & Rolf Holle & Reiner Leidl, 2019. "Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study," Health Economics Review, Springer, vol. 9(1), pages 1-11, December.

   Cited by:

   1. Murong Yang & Laurence S. J. Roope & James Buchanan & Arthur E. Attema & Philip M. Clarke & A. Sarah Walker & Sarah Wordsworth, 2022. "Eliciting risk preferences that predict risky health behavior: A comparison of two approaches," Health Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 836-858, May.
   2. Shai, Ori, 2022. "Out of time? The effect of an infrequent traumatic event on individuals’ time and risk preferences, beliefs, and insurance purchasing," Journal of Health Economics, Elsevier, vol. 86(C).

Articles

1. Kristina Burström & Fitsum Sebsibe Teni & Ulf-G. Gerdtham & Reiner Leidl & Gert Helgesson & Ola Rolfson & Martin Henriksson, 2020. "Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States," PharmacoEconomics, Springer, vol. 38(8), pages 839-856, August.

   Cited by:

   1. Huang, Li & Devlin, Nancy & Chen, Gang & Dalziel, Kim, 2024. "A happiness approach to valuing health states for children," Social Science & Medicine, Elsevier, vol. 348(C).
   2. Eva-Carin Lindgren & Jeanette Källstrand & Åsa Alftberg & Pia Johansson & Lars Kristén & Linn Håman & Andreas Ivarsson & Ing-Marie Carlsson, 2022. "Empowerment-Based Physical Activity Intervention for People with Advanced Dry Age-Related Macular Degeneration: Mixed-Methods Protocol," IJERPH, MDPI, vol. 20(1), pages 1-12, December.
   3. Mathilde Sengoelge & Alexander Nissen & Øivind Solberg, 2022. "Post-Migration Stressors and Health-Related Quality of Life in Refugees from Syria Resettled in Sweden," IJERPH, MDPI, vol. 19(5), pages 1-14, February.
   4. Persson, Ulf & Olofsson, Sara, 2020. "Quality-of-Life in the Swedish general population during Covid-19 – based on measurement pre- and post pandemic outbreak," IHE Report / IHE Rapport 2020:7, IHE - The Swedish Institute for Health Economics.
   5. Sun Sun & Håkan Jonsson & Klas-Göran Salén & Mats Andén & Lars Beckman & Per Fransson, 2023. "Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(2), pages 237-246, March.

2. Florian Kirsch & Christian Becker & Anja Schramm & Werner Maier & Reiner Leidl, 2020. "Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, h," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 607-619, June.

   Cited by:

   1. Dröge, Patrik & Ruhnke, Thomas & Fischer-Rosinsky, Antje & Henschke, Cornelia & Keil, Thomas & Möckel, Martin & Günster, Christian & Slagman, Anna, 2023. "Patients pathways before and after treatments in emergency departments: A retrospective analysis of secondary data in Germany," Health Policy, Elsevier, vol. 138(C).

3. Johanna I. Lutter & Boglárka Szentes & Margarethe E. Wacker & Joachim Winter & Sebastian Wichert & Annette Peters & Rolf Holle & Reiner Leidl, 2019. "Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study," Health Economics Review, Springer, vol. 9(1), pages 1-11, December.
   • Lutter, Johanna I. & Szentes, Boglarka & Wacker, Margarethe E. & Winter, Joachim & Wichert, Sebastian & Peters, Annette & Holle, Rolf & Leidl, Reiner, 2019. "Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study," Munich Reprints in Economics 78227, University of Munich, Department of Economics.
   See citations under working paper version above.
4. Manuel B. Huber & Julia Felix & Martin Vogelmann & Reiner Leidl, 2017. "Health-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5L," IJERPH, MDPI, vol. 14(4), pages 1-12, April.

   Cited by:

   1. Marta Encheva & Slaveyko Djambazov & Toni Vekov & Dominik Golicki, 2020. "EQ-5D-5L Bulgarian population norms," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1169-1178, November.
   2. Alina Geprägs & David Bürgin & Jörg M. Fegert & Elmar Brähler & Vera Clemens, 2022. "The Impact of Mental Health and Sociodemographic Characteristics on Quality of Life and Life Satisfaction during the Second Year of the COVID-19 Pandemic—Results of a Population-Based Survey in German," IJERPH, MDPI, vol. 19(14), pages 1-11, July.

5. Manuel B. Huber & Peter Reitmeir & Martin Vogelmann & Reiner Leidl, 2016. "EQ-5D-5L in the General German Population: Comparison and Evaluation of Three Yearly Cross-Section Surveys," IJERPH, MDPI, vol. 13(3), pages 1-12, March.

   Cited by:

   1. Ulrike Kuchenbecker & Daniela Chase & Anika Reichert & Julia Schiffner-Rohe & Mark Atwood, 2018. "Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-23, May.
   2. Manuel B. Huber & Julia Felix & Martin Vogelmann & Reiner Leidl, 2017. "Health-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5L," IJERPH, MDPI, vol. 14(4), pages 1-12, April.

6. Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle, 2015. "Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 671-681, July.

   Cited by:

   1. J. Pöhlmann & K. Norrbacka & K. S. Boye & W. J. Valentine & H. Sapin, 2020. "Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1179-1196, November.

7. Maximilian Hatz & Reiner Leidl & Nichola Yates & Björn Stollenwerk, 2014. "A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention," PharmacoEconomics, Springer, vol. 32(4), pages 377-393, April.

   Cited by:

   1. Zhi Qu & Shanshan Zhang & Christian Krauth & Xuenan Liu, 2019. "A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-17, May.

8. Sabine Witt & Reiner Leidl & Christian Becker & Rolf Holle & Michael Block & Johannes Brachmann & Sigmund Silber & Björn Stollenwerk, 2014. "The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data," PLOS ONE, Public Library of Science, vol. 9(12), pages 1-17, December.

   Cited by:

   1. Becker, Christian & Holle, Rolf & Stollenwerk, Björn, 2015. "The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention," Health Policy, Elsevier, vol. 119(6), pages 778-786.

9. Batscheider, Ariane & Rzehak, Peter & Teuner, Christina M. & Wolfenstetter, Silke B. & Leidl, Reiner & von Berg, Andrea & Berdel, Dietrich & Hoffmann, Barbara & Heinrich, Joachim, 2014. "Development of BMI values of German children and their healthcare costs," Economics & Human Biology, Elsevier, vol. 12(C), pages 56-66.

   Cited by:

   1. Millimet, Daniel L. & Tchernis, Rusty, 2015. "Persistence in body mass index in a recent cohort of US children," Economics & Human Biology, Elsevier, vol. 17(C), pages 157-176.
   2. Kinge, Jonas Minet & Morris, Stephen, 2014. "Association between obesity and prescribed medication use in England," Economics & Human Biology, Elsevier, vol. 15(C), pages 47-55.
   3. Matthias Eckardt & Christian Brettschneider & Hendrik van den Bussche & Hans‐Helmut König & MultiCare Study Group, 2017. "Analysis of Health Care Costs in Elderly Patients with Multiple Chronic Conditions Using a Finite Mixture of Generalized Linear Models," Health Economics, John Wiley & Sons, Ltd., vol. 26(5), pages 582-599, May.
   4. Tobias Effertz & Susanne Engel & Frank Verheyen & Roland Linder, 2016. "The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(9), pages 1141-1158, December.
   5. Black, Nicole & Hughes, Robert & Jones, Andrew M., 2018. "The health care costs of childhood obesity in Australia: An instrumental variables approach," Economics & Human Biology, Elsevier, vol. 31(C), pages 1-13.

10. Katharina Fischer & Reiner Leidl, 2014. "Analysing coverage decision-making: opening Pandora’s box?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 899-906, December.

    Cited by:

    1. Peter Ghijben & Yuanyuan Gu & Emily Lancsar & Silva Zavarsek, 2018. "Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review," PharmacoEconomics, Springer, vol. 36(3), pages 323-340, March.
    2. Fischer, Katharina Elisabeth & Heisser, Thomas & Stargardt, Tom, 2016. "Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia," Health Policy, Elsevier, vol. 120(10), pages 1115-1122.

11. Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.

    Cited by:

    1. Maynou, Laia & Cairns, John, 2018. "What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries," LSE Research Online Documents on Economics 90877, London School of Economics and Political Science, LSE Library.
    2. Katharina Elisabeth Fischer & Wolf Henning Rogowski, 2014. "Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe," IJERPH, MDPI, vol. 11(5), pages 1-28, May.
    3. Maynou, Laia & Cairns, John, 2019. "What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries," Health Policy, Elsevier, vol. 123(2), pages 130-139.
    4. Katharina Fischer & Reiner Leidl, 2014. "Analysing coverage decision-making: opening Pandora’s box?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 899-906, December.
    5. Chris Schilling & Duncan Mortimer & Kim Dalziel, 2017. "Using CART to Identify Thresholds and Hierarchies in the Determinants of Funding Decisions," Medical Decision Making, , vol. 37(2), pages 173-182, February.
    6. Wolf Rogowski & Katherine Payne & Petra Schnell-Inderst & Andrea Manca & Ursula Rochau & Beate Jahn & Oguzhan Alagoz & Reiner Leidl & Uwe Siebert, 2015. "Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation," PharmacoEconomics, Springer, vol. 33(1), pages 49-59, January.

12. Petra Menn & Reiner Leidl & Rolf Holle, 2012. "A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease," PharmacoEconomics, Springer, vol. 30(9), pages 825-840, September.

    Cited by:

    1. Mohsen Sadatsafavi & Shahzad Ghanbarian & Amin Adibi & Kate Johnson & J. Mark FitzGerald & William Flanagan & Stirling Bryan & Don Sin, 2019. "Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada," Medical Decision Making, , vol. 39(2), pages 152-167, February.
    2. Benjamin Cadier & Isabelle Durand-Zaleski & Daniel Thomas & Karine Chevreul, 2016. "Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-17, February.
    3. Keith Anderson & Tomasz Zastawniak, 2017. "Glamour, value and anchoring on the changing /," The European Journal of Finance, Taylor & Francis Journals, vol. 23(5), pages 375-406, April.
    4. Saligrama Agnihothri & Leon Cui & Mohammad Delasay & Balaraman Rajan, 2020. "The value of mHealth for managing chronic conditions," Health Care Management Science, Springer, vol. 23(2), pages 185-202, June.
    5. Yumi Asukai & Michael Baldwin & Tiago Fonseca & Alastair Gray & Laura Mungapen & David Price, 2013. "Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling," PharmacoEconomics, Springer, vol. 31(2), pages 151-161, February.

13. Breitfelder, Ariane & Wenig, Christina M. & Wolfenstetter, Silke B. & Rzehak, Peter & Menn, Petra & John, Jürgen & Leidl, Reiner & Bauer, Carl Peter & Koletzko, Sibylle & Röder, Stefan & Herbarth, Olf, 2011. "Relative weight-related costs of healthcare use by children--Results from the two German birth cohorts, GINI-plus and LISA-plus," Economics & Human Biology, Elsevier, vol. 9(3), pages 302-315, July.

    Cited by:

    1. Buchmueller, Thomas C. & Johar, Meliyanni, 2015. "Obesity and health expenditures: Evidence from Australia," Economics & Human Biology, Elsevier, vol. 17(C), pages 42-58.
    2. Kinge, Jonas Minet & Morris, Stephen, 2014. "Association between obesity and prescribed medication use in England," Economics & Human Biology, Elsevier, vol. 15(C), pages 47-55.
    3. Rahkovsky, Ilya & Gregory, Christian A., 2013. "Food prices and blood cholesterol," Economics & Human Biology, Elsevier, vol. 11(1), pages 95-107.
       • Rahkovsky, Ilya & Gregory, Christian A., 2011. "Food Prices and Blood Cholesterol," 2011 Annual Meeting, July 24-26, 2011, Pittsburgh, Pennsylvania 103566, Agricultural and Applied Economics Association.
    4. Batscheider, Ariane & Rzehak, Peter & Teuner, Christina M. & Wolfenstetter, Silke B. & Leidl, Reiner & von Berg, Andrea & Berdel, Dietrich & Hoffmann, Barbara & Heinrich, Joachim, 2014. "Development of BMI values of German children and their healthcare costs," Economics & Human Biology, Elsevier, vol. 12(C), pages 56-66.
    5. Mora, Toni & Llargués, Esteve & Recasens, Assumpta, 2015. "Does health education affect BMI? Evidence from a school-based randomised-control trial," Economics & Human Biology, Elsevier, vol. 17(C), pages 190-201.
    6. Black, Nicole & Hughes, Robert & Jones, Andrew M., 2018. "The health care costs of childhood obesity in Australia: An instrumental variables approach," Economics & Human Biology, Elsevier, vol. 31(C), pages 1-13.
    7. Fenske Nora & Fahrmeir Ludwig & Hothorn Torsten & Rzehak Peter & Höhle Michael, 2013. "Boosting Structured Additive Quantile Regression for Longitudinal Childhood Obesity Data," The International Journal of Biostatistics, De Gruyter, vol. 9(1), pages 1-18, July.

14. Fischer, Katharina E. & Leidl, Reiner & Rogowski, Wolf H., 2011. "A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention," Health Policy, Elsevier, vol. 101(3), pages 290-299, August.

    Cited by:

    1. Katharina Elisabeth Fischer & Wolf Henning Rogowski, 2014. "Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe," IJERPH, MDPI, vol. 11(5), pages 1-28, May.
    2. Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.
    3. Katharina Fischer & Reiner Leidl, 2014. "Analysing coverage decision-making: opening Pandora’s box?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 899-906, December.
    4. Katharina E. Fischer & Björn Stollenwerk & Wolf H. Rogowski, 2013. "Link between Process and Appraisal in Coverage Decisions," Medical Decision Making, , vol. 33(8), pages 1009-1025, November.
    5. Fischer, Katharina Elisabeth, 2012. "A systematic review of coverage decision-making on health technologies—Evidence from the real world," Health Policy, Elsevier, vol. 107(2), pages 218-230.

15. Wilm Quentin & Simone Neubauer & Reiner Leidl & Hans-Helmut König, 2007. "Advertising bans as a means of tobacco control policy: a systematic literature review of time-series analyses," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 52(5), pages 295-307, October.

    Cited by:

    1. Florentine Petronella Martino & Peter Graeme Miller & Kerri Coomber & Linda Hancock & Kypros Kypri, 2017. "Analysis of Alcohol Industry Submissions against Marketing Regulation," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-22, January.
    2. Tamara Schikowski & Nino Künzli, 2009. "A little bit is not good enough: comprehensive smoking control is needed," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 54(6), pages 365-366, December.

16. Renee Stark & Hans-Helmut König & Reiner Leidl, 2006. "Costs of Inflammatory Bowel Disease in Germany," PharmacoEconomics, Springer, vol. 24(8), pages 797-814, August.

    Cited by:

    1. Andersen, Signe Hald, 2010. "The cost of sickness: On the effect of the duration of sick leave on post-sick leave earnings," Social Science & Medicine, Elsevier, vol. 70(10), pages 1581-1589, May.
    2. Marina Kostić & Ljiljan Djakovic & Raša Šujić & Brian Godman & Slobodan M. Janković, 2017. "Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications," Applied Health Economics and Health Policy, Springer, vol. 15(1), pages 85-93, February.
    3. Anne Prenzler & Bernd Bokemeyer & J.-Matthias Schulenburg & Thomas Mittendorf, 2011. "Health care costs and their predictors of inflammatory bowel diseases in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(3), pages 273-283, June.
    4. Mirthe E van der Valk & Marie-Josée J Mangen & Mirjam Severs & Mike van der Have & Gerard Dijkstra & Ad A van Bodegraven & Herma H Fidder & Dirk J de Jong & C Janneke van der Woude & Mariëlle J L Romb, 2016. "Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-11, April.
    5. Przemysław Holko & Paweł Kawalec & Magdalena Sajak-Szczerba & Luisa Avedano & Małgorzata Mossakowska, 2023. "Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(7), pages 1073-1083, September.
    6. Przemysław Holko & Paweł Kawalec & Małgorzata Mossakowska & Andrzej Pilc, 2016. "Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-21, December.
    7. Renata S. B. Fróes & Ana Teresa Pugas Carvalho & Antonio Jose V. Carneiro & Adriana Maria Hilu Barros Moreira & Jessica P. L. Moreira & Ronir R. Luiz & Heitor S. de Souza, 2018. "The socio-economic impact of work disability due to inflammatory bowel disease in Brazil," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(3), pages 463-470, April.

17. D. Stratmann‐Schoene & T. Kuehn & R. Kreienberg & R. Leidl, 2006. "A preference‐based index for the SF‐12," Health Economics, John Wiley & Sons, Ltd., vol. 15(6), pages 553-564, June.

    Cited by:

    1. Duncan Mortimer & Leonie Segal, 2008. "Comparing the Incomparable? A Systematic Review of Competing Techniques for Converting Descriptive Measures of Health Status into QALY-Weights," Medical Decision Making, , vol. 28(1), pages 66-89, January.
    2. Anirban Basu & William Dale & Arthur Elstein & David Meltzer, 2009. "A linear index for predicting joint health‐states utilities from single health‐states utilities," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 403-419, April.
    3. Peasgood, T & Ward, S & Brazier, J, 2010. "A review and meta-analysis of health state utility values in breast cancer," MPRA Paper 29950, University Library of Munich, Germany.

18. Breyer, Friedrich & Adam, Hans & Cassel, Dieter & Daumann, Frank & Eisen, Roland & Felder, Stefan & Jacobs, Klaus & Karmann, Alexander & Kifmann, Mathias & Kliemt, Hartmut & Krämer, Walter & Leidl, Re, 2006. "Gesundheitspolitik in der Kompromissfalle: Kein Problem gelöst, aber neue geschaffen," Wirtschaftsdienst – Zeitschrift für Wirtschaftspolitik (1949 - 2007), ZBW - Leibniz Information Centre for Economics, vol. 86(8), pages 515-516.

    Cited by:

    1. Boss, Alfred, 2006. "Zur geplanten Reform des Gesundheitswesens," Open Access Publications from Kiel Institute for the World Economy 3895, Kiel Institute for the World Economy (IfW Kiel).

19. Thomas Hammerschmidt & Hans‐Peter Zeitler & Reiner Leidl, 2004. "A utility‐theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test," Health Economics, John Wiley & Sons, Ltd., vol. 13(4), pages 345-361, April.

    Cited by:

    1. Isabell Goldberg & Jutta Roosen, 2007. "Scope insensitivity in health risk reduction studies: A comparison of choice experiments and the contingent valuation method for valuing safer food," Journal of Risk and Uncertainty, Springer, vol. 34(2), pages 123-144, April.
    2. Bernard van den Berg & Han Bleichrodt & Louis Eeckhoudt, 2005. "The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care," Health Economics, John Wiley & Sons, Ltd., vol. 14(4), pages 363-376, April.
       • B. van den Berg & H. Bleichrodt & L. Eeckhoudt, 2005. "The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care," Post-Print hal-00200697, HAL.

20. Schulz, Erika & Leidl, Reiner & Konig, Hans-Helmut, 2004. "The impact of ageing on hospital care and long-term care--the example of Germany," Health Policy, Elsevier, vol. 67(1), pages 57-74, January.

    Cited by:

    1. Kuhn, Michael & Nuscheler, Robert, 2011. "Optimal public provision of nursing homes and the role of information," Journal of Health Economics, Elsevier, vol. 30(4), pages 795-810, July.
    2. Vogt, Tobias C. & Kluge, Fanny A., 2015. "Can public spending reduce mortality disparities? Findings from East Germany after reunification," The Journal of the Economics of Ageing, Elsevier, vol. 5(C), pages 7-13.
    3. Nuscheler, Robert & Roeder, Kerstin, 2013. "The political economy of long-term care," Munich Reprints in Economics 19324, University of Munich, Department of Economics.
       • Nuscheler, Robert & Roeder, Kerstin, 2013. "The political economy of long-term care," European Economic Review, Elsevier, vol. 62(C), pages 154-173.
    4. Melanie Arntz & Stephan L. Thomsen, 2010. "The Social Long-term Care Insurance: A Frail Pillar of the German Social Insurance System," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 8(02), pages 29-34, July.
    5. Arntz Melanie & Thomsen Stephan L., 2010. "Are Personal Budgets a Financially Sound Reform Option for the German Long-Term Care Insurance?," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 230(4), pages 378-402, August.
    6. Paolo Malighetti & Stefano Paleari & Renato Redondi, 2005. "Financing and Managing Health Expenditure: Evaluation of Aging and Capitation Criteria in the Italian Healthcare System," Working Papers 0504, Department of Management, Information and Production Engineering, University of Bergamo.
    7. Stefan Felder, 2006. "Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie," Perspektiven der Wirtschaftspolitik, Verein für Socialpolitik, vol. 7(s1), pages 49-73, May.
    8. T. Lehnert & O. H. Günther & A. Hajek & S. G. Riedel-Heller & H. H. König, 2018. "Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(9), pages 1213-1223, December.
    9. Murphy, Michael & Martikainen, Pekka, 2013. "Use of hospital and long-term institutional care services in relation to proximity to death among older people in Finland," Social Science & Medicine, Elsevier, vol. 88(C), pages 39-47.
    10. Kildemoes, Helle Wallach & Christiansen, Terkel & Gyrd-Hansen, Dorte & Kristiansen, Ivar Sonbo & Andersen, Morten, 2006. "The impact of population ageing on future Danish drug expenditure," Health Policy, Elsevier, vol. 75(3), pages 298-311, February.
    11. Breyer, Friedrich & Felder, Stefan, 2006. "Life expectancy and health care expenditures: A new calculation for Germany using the costs of dying," Health Policy, Elsevier, vol. 75(2), pages 178-186, January.
        • Friedrich Breyer & Stefan Felder, 2004. "Life Expectancy and Health Care Expenditures: A New Calculation for Germany Using the Costs of Dying," Discussion Papers of DIW Berlin 452, DIW Berlin, German Institute for Economic Research.
    12. Peng, Rong & Ling, Li & He, Qun, 2010. "Self-rated health status transition and long-term care need, of the oldest Chinese," Health Policy, Elsevier, vol. 97(2-3), pages 259-266, October.
    13. Fanny A. Kluge & Emilio Zagheni & Elke Loichinger & Tobias C. Vogt, 2014. "The advantages of demographic change after the wave: fewer and older, but healthier, greener, and more productive?," MPIDR Working Papers WP-2014-003, Max Planck Institute for Demographic Research, Rostock, Germany.
    14. Arntz, Melanie & Thomsen, Stephan L., 2008. "Reforming Home Care Provision in Germany: Evidence from a Social Experiment," ZEW Discussion Papers 08-114, ZEW - Leibniz Centre for European Economic Research.
    15. Joan Costa-Font & Raphael Wittenberg & Concepció Patxot & Adelina Comas-Herrera & Cristiano Gori & Alessandra di Maio & Linda Pickard & Alessandro Pozzi & Heinz Rothgang, 2008. "Projecting Long-Term Care Expenditure in Four European Union Member States: The Influence of Demographic Scenarios," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 86(2), pages 303-321, April.
    16. Byaro, Mwoya & Kinyondo, Abel & Michello, Charles & Musonda, Patrick, 2018. "Determinants of Public Health Expenditure Growth in Tanzania: An Application of Bayesian Model," African Journal of Economic Review, African Journal of Economic Review, vol. 6(1), January.
    17. Amin Mahmoudian-Dehkordi & Somayeh Sadat, 2017. "Sustaining critical care: using evidence-based simulation to evaluate ICU management policies," Health Care Management Science, Springer, vol. 20(4), pages 532-547, December.

21. Reiner Leidl, 2003. "Medical Progress and Supplementary Private Health Insurance," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 28(2), pages 222-237, April.

    Cited by:

    1. Reiner Leidl, 2008. "A model to decompose the performance of supplementary private health insurance markets," International Journal of Health Economics and Management, Springer, vol. 8(3), pages 193-208, September.

22. A. Müller & D. Stratmann-Schöne & T. Klose & R. Leidl, 2002. "Overview of economic evaluation of positron-emission tomography," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(1), pages 59-65, March.

    Cited by:

    1. Paolo Pertile, 2009. "An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography," International Journal of Health Economics and Management, Springer, vol. 9(3), pages 317-332, September.

23. Erika Schulz & Reiner Leidl & Hans-Helmut König, 2001. "Starker Anstieg der Pflegebedürftigkeit zu erwarten: Vorausschätzungen bis 2020 mit Ausblick auf 2050," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 68(5), pages 65-77.

    Cited by:

    1. Keck, Wolfgang & Saraceno, Chiara, 2009. "Balancing elderly care and employment in Germany," Discussion Papers, Research Professorship Demographic Development, Social Change, and Social Capital SP I 2009-401, WZB Berlin Social Science Center.

24. Mariëlle E.J.B. Goossens & Maureen P.M.H. Rutten‐Van Mölken & Ank M.J. Kole‐Snijders & Johan W.S. Vlaeyen & Gerard Van Breukelen & Reiner Leidl, 1998. "Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 39-51, February.

    Cited by:

    1. Arndt R. Reichert & Boris Augurzky & Harald Tauchmann, 2015. "Self‐Perceived Job Insecurity And The Demand For Medical Rehabilitation: Does Fear Of Unemployment Reduce Health Care Utilization?," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 8-25, January.

25. Postma, Maarten J. & Tolley, Keith & Leidl, Reiner M. & Downs, Angela M. & Beck, Eduard J. & Tramarin, Andrea M. & Flori, Yves A. & Santin, Miguel & Antonanzas, Fernando & Kornarou, Helen & Paparizos,, 1997. "Hospital care for persons with AIDS in the European Union," Health Policy, Elsevier, vol. 41(2), pages 157-176, August.

    Cited by:

    1. Atun, Rifat A. & McKee, Martin & Coker, Richard & Gurol-Urganci, Ipek, 2008. "Health systems' responses to 25 years of HIV in Europe: Inequities persist and challenges remain," Health Policy, Elsevier, vol. 86(2-3), pages 181-194, May.
    2. Keith Tolley;Gareth Morgan;Ray Cartwright;Rhys Williams, 1998. "Economic Aspects of Non-Hodgkin's Lymphoma," Series on Health 000436, Office of Health Economics.

26. Rob Baltussen & Reiner Leidl & André Ament, 1996. "The impact of age on cost‐effectiveness ratios and its control in decision making," Health Economics, John Wiley & Sons, Ltd., vol. 5(3), pages 227-239, May.

    Cited by:

    1. Spath, Hans-Martin & Carrere, Marie-Odile & Fervers, Beatrice & Philip, Thierry, 1999. "Analysis of the eligibility of published economic evaluations for transfer to a given health care system: Methodological approach and application to the French health care system," Health Policy, Elsevier, vol. 49(3), pages 161-177, November.
    2. Klose, Thomas, 2002. "Life-cycle preferences over consumption and health: a comment on Bleichrodt and Quiggin," Journal of Health Economics, Elsevier, vol. 21(1), pages 161-166, January.

27. Baltussen, Rob & Ament, Andre & Leidl, Reiner, 1996. "Making cost assessments based on RCTs more useful to decision-makers," Health Policy, Elsevier, vol. 37(3), pages 163-183, September.

    Cited by:

    1. Uwe Siebert, 2003. "When should decision-analytic modeling be used in the economic evaluation of health care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 143-150, September.
    2. Christopher J.L. Murray & David B. Evans & Arnab Acharya & Rob M.P.M. Baltussen, 2000. "Development of WHO guidelines on generalized cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 9(3), pages 235-251, April.
    3. Rob Baltussen & Reiner Leidl & André Ament, 1996. "The impact of age on cost‐effectiveness ratios and its control in decision making," Health Economics, John Wiley & Sons, Ltd., vol. 5(3), pages 227-239, May.
    4. Cleemput, Irina & Kesteloot, Katrien & DeGeest, Sabina, 2002. "A review of the literature on the economics of noncompliance. Room for methodological improvement," Health Policy, Elsevier, vol. 59(1), pages 65-94, January.

28. Postma, Maarten J. & Jager, Johannes C. & Dijgraaf, Marcel G. W. & Borleffs, Jan C. C. & Tolley, Keith & Leidl, Reiner M., 1995. "AIDS scenarios for The Netherlands; the economic impact on hospitals," Health Policy, Elsevier, vol. 31(2), pages 127-150, February.

    Cited by:

    1. Postma, Maarten J. & Jager, Johannes C. & Ruwaard, Dirk & van Loy, Nicole C. M. & Leidl, Reiner M., 1998. "Disease-staging for modelling current and future health-care impact of disease: illustrations for Diabetes Mellitus and AIDS," Health Policy, Elsevier, vol. 43(1), pages 45-54, January.
    2. Dijkgraaf, Marcel G. W. & Luijben, August H. P. & Postma, Maarten J. & Borleffs, Jan C. C. & Schrijvers, August J. P. & Jager, Johannes C., 1996. "Lifetime hospitalization profiles for symptomatic, HIV-infected persons," Health Policy, Elsevier, vol. 35(1), pages 13-32, January.
    3. Postma, Maarten J. & Tolley, Keith & Leidl, Reiner M. & Downs, Angela M. & Beck, Eduard J. & Tramarin, Andrea M. & Flori, Yves A. & Santin, Miguel & Antonanzas, Fernando & Kornarou, Helen & Paparizos,, 1997. "Hospital care for persons with AIDS in the European Union," Health Policy, Elsevier, vol. 41(2), pages 157-176, August.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Reiner Martin Leidl should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.